Aehr Test Systems (AEHR)
NASDAQ: AEHR
· Real-Time Price · USD
26.97
-1.81 (-6.29%)
At close: Sep 16, 2025, 12:06 PM
Aehr Test Systems Revenue Breakdown
| Period Ending | Feb 28, 2025 | Nov 29, 2024 | Aug 30, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products Revenue | 16.68M | 1.47M | 965K | 1.59M | 1.27M | 1.29M | 902K | 739K | 584K | 779K | 879K | 801K | 949K | 985K | 1.31M | 1.26M | 1.78M |
| Products Revenue Growth | +1036.31% | +52.12% | -39.46% | +25.81% | -1.63% | +42.79% | +22.06% | +26.54% | -25.03% | -11.38% | +9.74% | -15.60% | -3.65% | -25.04% | +4.62% | -29.48% | n/a |
| Services Revenue | 1.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Services Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Nov 29, 2024 | Aug 30, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Revenue | 9.82M | 12.58M | 52.91M | 5.17M | 18.92M | 19.23M | 5.35M | 4.12M | 632K | 969K | 2.8M | 891K | 3.53M | 338K | 1.83M | 746K | 1.33M |
| Asia Revenue Growth | -21.89% | -76.23% | +923.98% | -72.69% | -1.61% | +259.39% | +29.82% | +552.22% | -34.78% | -65.37% | +214.03% | -74.75% | +944.08% | -81.57% | +145.84% | -44.08% | n/a |
| Europe Revenue | 166K | 18K | 3.85M | 756K | 1.83M | 604K | 25K | 32K | 81K | 2K | 129K | 206K | 718K | 138K | 1.35M | 214K | 68K |
| Europe Revenue Growth | +822.22% | -99.53% | +409.79% | -58.76% | +203.48% | +2316.00% | -21.88% | -60.49% | +3950.00% | -98.45% | -37.38% | -71.31% | +420.29% | -89.76% | +529.44% | +214.71% | n/a |
| United States Revenue | 3.46M | 523K | n/a | n/a | n/a | n/a | 2.26M | 1.11M | 970K | 1.04M | 846K | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +561.95% | n/a | n/a | n/a | n/a | n/a | +103.23% | +14.74% | -6.82% | +23.05% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | May 30, 2025 | Feb 28, 2025 | Nov 29, 2024 | Aug 30, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 30, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.93M | 5.16M | 4.64M | 4.56M | 3.76M | 3.06M | 3.52M | 3.41M | 3.59M | 3.25M | 2.88M | 2.52M | 2.99M | 2.61M | 2.49M | 1.95M | 1.9M | 1.64M | 1.5M | 1.51M | 1.67M | 1.89M | 2.16M | 1.81M | 2.02M | 1.85M | 1.98M | 1.88M | 1.82M | 1.83M | 1.85M | 1.79M | 1.91M | 1.72M | 1.71M | 1.72M | 1.72M | 1.7M | 1.71M | 1.84M | 1.53M | 1.58M |
| Selling, General, and Administrative Revenue Growth | -23.94% | +11.32% | +1.73% | +21.35% | +22.62% | -12.93% | +3.20% | -4.96% | +10.37% | +13.04% | +13.86% | -15.64% | +14.59% | +4.94% | +27.44% | +2.57% | +15.89% | +9.46% | -0.86% | -9.56% | -11.48% | -12.33% | +19.30% | -10.41% | +9.08% | -6.42% | +5.22% | +3.47% | -0.71% | -1.35% | +3.52% | -5.98% | +10.50% | +1.00% | -0.52% | -0.35% | +1.59% | -1.05% | -7.15% | +20.90% | -3.66% | n/a |
| Research and Development Revenue | 2.69M | 3.14M | 2.28M | 2.36M | 2.15M | 2.14M | 1.97M | 2.46M | 2.25M | 1.83M | 1.55M | 1.5M | 1.66M | 1.53M | 1.31M | 1.32M | 1.03M | 903K | 820K | 900K | 854K | 845K | 795K | 892K | 1.12M | 931K | 986K | 1.12M | 1.1M | 1.04M | 1.09M | 955K | 1.31M | 1.25M | 1.04M | 1.06M | 1.05M | 1.29M | 923K | 1.06M | 967K | 1.03M |
| Research and Development Revenue Growth | -14.46% | +37.96% | -3.60% | +9.76% | +0.56% | +8.47% | -19.74% | +9.05% | +22.98% | +18.12% | +3.54% | -9.49% | +8.24% | +16.45% | -0.61% | +28.38% | +13.95% | +10.12% | -8.89% | +5.39% | +1.07% | +6.29% | -10.87% | -20.36% | +20.30% | -5.58% | -11.65% | +1.82% | +5.38% | -4.59% | +14.14% | -27.04% | +4.89% | +20.00% | -1.89% | +1.34% | -19.10% | +40.09% | -13.09% | +9.82% | -6.21% | n/a |